A Time-Structured Observational Framework for A3 Adenosine Receptor Perturbation

This record documents version 2.2 of an evolving conceptual series examining A3 adenosine receptor (A3AR)–associated biology. Earlier versions (v2.0 and v2.1) explored potential interactions between A3AR modulation and immune components, with attention to combinatorial concepts and, transiently, to spatial or delivery-related considerations. Re-examination of those earlier frameworks suggested that such features may obscure a more fundamental variable: time. Accordingly, v2.2 reframes the prior work by identifying temporal structure as a potentially independent experimental axis. In this version, A3AR-associated intervention is treated as a finite, time-delimited biological event, rather than a sustained pharmacological state. The framework intentionally adopts a conservative, text-only approach and considers a non-invasive intravenous (IV) pulse solely as a means to define explicit pharmacodynamic termination (PD OFF). The primary objective is not to propose a therapeutic strategy or evaluate drug efficacy, but to establish interpretable temporal boundaries that may clarify downstream biological observations. Within this structure, natural killer (NK) cells are positioned as a temporal readout rather than a synergistic therapy. The central question addressed in v2.2 is whether a transient, time-restricted window of altered NK susceptibility can be meaningfully observed following A3AR-associated perturbation. Invasive delivery strategies and claims of clinical feasibility or therapeutic value are intentionally excluded.